Back to team overview
Dr. Andreas Ledl
Partner
German Patent Attorney
European Patent Attorney
UPC Representative
Biochemist
Andreas´ expertise extends to all aspects of intellectual property protection in the fields of pharmaceuticals, biotechnology and biochemistry. He has extensive experience in patent prosecution and advises on strategy and management of patent portfolios in the most important jurisdictions worldwide. He has particular experience in grant, opposition and appeal proceedings before the European Patent Office. He regularly prepares freedom-to-operate, validity and due diligence analyses for clients.
A particular achievement has been the creation of an extensive patent portfolio for a successful/leading opioid-based analgesic.
since 2015
Partner, shareholder and managing director at Maiwald
since 2010
Patent attorney at Maiwald
2006 - 2010
Patent attorney trainee at Maiwald
2023
Admitted to practice before the UPC
2010
Admitted to practice as European patent attorney
2010
Admitted to practice as German patent attorney
2006 - 2009
Studied law for patent attorneys at the University of Hagen
2001 - 2006
Doctoral degree in the field of biochemistry from the Ludwig Maximilian University of Munich (doctoral research at the Max Planck Institute of Biochemistry)
1995 - 2001
Studied biochemistry at the University of Regensburg and at the Wesleyan University
- Patent prosecution and portfolio management
- Filing strategies and drafting patent applications
- Freedom-to-operate and validity opinions
- Opposition and nullity proceedings
- Recommended in IAM Patent 1000 “World’s Leading Patent Professionals” 2020, 2021, 2022, 2023, 2024
- Recommended in Legal 500 EMEA 2023, 2024
- Recommended in Legal 500 Deutschland 2023, 2024
- Listed in IAM Strategy 300 Global Leaders 2024, 2025
- Listed in IAM Strategy 300 as one of the world's leading IP strategists 2023, 2024
- Recommended in MIP IP Stars 2017
- German Patent Attorney Association
- epi
- German
- English
